Hepatitis C virus infection in Taiwan: Past, present, and future
Journal
Journal of the Formosan Medical Association
Journal Volume
115
Journal Issue
2
Pages
65-66
Date Issued
2016
Author(s)
SDGs
Other Subjects
asunaprevir plus beclabuvir plus daclatasvir; boceprevir; elbasvir plus grazoprevir; interferon; ledipasvir plus sofosbuvir; ombitasvir plus paritaprevir plus ritonavir; ribavirin; simeprevir; sofosbuvir; telaprevir; alpha interferon; antivirus agent; ribavirin; hepatitis C; Hepatitis C virus genotype 1; human; Short Survey; single nucleotide polymorphism; Taiwan; treatment response; drug effects; genetics; Hepacivirus; hepatitis C; public health; Antiviral Agents; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Public Health; Ribavirin; Taiwan
Publisher
Elsevier B.V.
Type
short survey